Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUTEP LIMITED Director's Dealing 2009

Apr 30, 2009

65122_rns_2009-04-30_abf4085e-c6c8-4a57-8c64-2e22329d9b4f.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

PRIMA BIOMED LIMITED (ASX: PRR)
Name of Entity:
ABN: 90 009 237 889

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: MR. ATA GOKYILDIRIM 11[th] June 2008 Date of Last Notice:

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or Indirect Interest Indirect Indirect
Nature of Indirect Interest(including registered holder) Note:Provide details of the circumstances giving rise to the relevantinterest. Director Related Entity
Date of change 30thApril 2009
No. of securities held prior to change Options-18,000,00018,000,000
Shares Options
Direct - -
Indirect - 18,000,000
Total - 18,000,000
Class Ordinary Shares (PRR)
Number Acquired Options---
Shares Options
Direct - -
Indirect 234,000 -
Total 234,000 -
Number Disposed Nil
Value/ConsiderationNote:If consideration is non-cash, provide details and estimated valuation $0.064 share
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

No. of Securities Held After Change Options-18,000,00018,000,000
Shares Options
Direct - -
Indirect 234,000 18,000,000
Total 234,000 18,000,000
Nature of ChangeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back Off-market transfer

Part 2 – Change of Director’s Interests in Contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of Contract Nature of Interest Name of Registered Holder (if issued securities) Date of Change No. and Class of Securities to Which Interest Related Prior to Change Note: Details are only required for a contract in relation to which the interest has changed Interest Acquired Interest Disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest After Change

==> picture [51 x 30] intentionally omitted <==

The CFO Solution

01.05.2009

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002